Hepatitis B and C virus infection and the hepatocellular carcinoma in the East Amazon, Brazil;Infecções pelos vírus das hepatites B e C e o carcinoma hepatocelular na Amazônia oriental

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 37, Issue SUPPL. 2, 2004, Pages 47-51

  Branco Mello Miranda, Esther Castello ^a,b,d   Pereira Mioa, Lizomar De Jesus ^a   Abraçado Amaral, Ivanete Do Socorro ^a   De Brito Barbosa, Maria Silvia ^a   Souza Da Silva Conde, Simone Regina ^a   Ferreira De Araújo, Marialva Tereza ^b   Moutinho Da Cruz, Ermelinda Do Rosário ^b   Demachki, Samia ^b   Bensabath, Gilberta ^c   Pereira Soares, Manoel Do Carmo ^c  

^a Hosp Fund S Casa Misericordia P   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

^d NONE   (Brazil)

Author keywords

Hepatitis B and C; Hepatocellular carcinoma; Molecular biology; Serology

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS RNA;

ADULT; ALCOHOLISM; ARTICLE; BRAZIL; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EPIDEMIOLOGICAL DATA; FEMALE; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 13844253369     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822004000700007     Document Type: Article

References (24)

1. Ayres M. BioEstat: aplicações estatísticas nas áreas das ciências biológicas e médicas. Sociedade Civil Mamirauã, Manaus, 1998.
2. Beasley RP, LIN CC, Hwang LL, Chien CS. Hepatocellular carcinoma and hepatitis B. A prospective study of 22.707 men in Taiwan. The Lancet 21: 1129-1133, 1981.
3. Castells L, Vargas V, Gonzales A, Esteban R, Esteban J, Guardia J. Long interval between HCV infection and development of hepatocellular carcinoma. Liver 15: 159-163, 1995.
4. Chang MH, Chen CJ, Lai MS. Universal hepatitis B vaccination in Taiwan and the incidence of hepstocelular carcinoma in children. New England Journal of Medicine 336: 1855-1859, 1997.
5. Colombo M, De Franchis R, Del Ninno E. Hepatocellular carcinoma in Italian pacientes with cirrhosis. The New England Journal of Medicine 325: 675-680, 1991.
6. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beaugrand M, Pisi E. HCV-associated liver cancer without cirrhosis. The Lancet 345: 413-415, 1995.
7. Fundação Nacional de Saúde. Mortalidade Brasil, 1992. Centre Nacional de Epidemiologia, Ministério da Saúde, Brasilia, 1996.
8. Gonçalves CS, Pereira FEL. Tumores de fígado. In: Dani R, Castro LP (eds) Gastroenterologia Clínica. Guanabara Koogan, Rio de Janeiro, p. 1455-1483, 1993.
9. Gonçalves CS, Pereira FEL, Gayotto LCC. Hepatocellular carcinoma in Brazil: Report of a national survey (Florianópolis, SC, 1995). Revista do Instituto de Medicina Tropical de São Paulo 39: 165-170, 1997.
10. Hollinger FB. Hepatitis B virus. In: Knipe DM, Howley PM (eds) Fields Virology. Lippincott-Raven Publishers, Philadelphia, p. 2739-2907, 1996.
11. Huo TI, Wu JC, Lee PC. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 28:231-236, 1998.
12. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. New England Journal of Medicine 340:798-799, 1999.
13. Kashala LO, Kalengayi MMR, Essex M. Alpha-fetoprotein human hepatocelular carcinoma: correlation with hepatitis B surface antigen expression. Cancer Investigation 10:513-522, 1992.
14. Kew MC. Tumors of the liver. In: Zakim D, Boyer TD (eds) Hepatology. A textbook of Liver Desease. WB Saunders Company, Philadelphia, p.1513-1564, 1996.
15. Kim GM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in trangenic mice. Nature 351:317-320, 1991
16. Lai MC, Tong MJ, Nowicki MJ, Lee SD. Is anti-HBc IgM a useful clinical test in acientswith HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma? Hepatology 8:514-517, 1988.
17. Liang TJ, Lenox JJ, Reddy KR. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18:1326-1333, 1993.
18. Nomura F, Ohnishi, K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 pacients. Cancer 64: 1700-1707, 1989.
19. Okuda K, Kojiro M, Hiroaki O. Neoplasms of de liver. In: Schift L, Schift ER (eds) Diseases of de Liver, WB, Saunders Co, Philadelphia, p. 1236-1396, 1993.
20. Ruiz J, Sangro B, Cuende JI. Hepatitis B and C viral infeccions in pacients with hepatocelular carcinoma. Hepatology 16:637-641, 1992.
21. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. The New England Journal of Medicine 305:1067-1073, 1981.
22. Sjogren MH, Dusheiko GM, Kew MC, Song E. Hepatitis B virus infection and hepatocellular carcinoma: correlation between IgM antibody to hepatitis B core antigen, hepatitis B e antigen, and hepatitis B DNA. American Journal Tropical Medicine Hygiene 39:582-585, 1988.
23. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata, M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients. Hepatology 21:651-655, 1995.
24. Wands JR, Blum HE. Primary hepatocellular carcinoma. The New England Journal of Medicine 325:729-731, 1991.